PCG
59
9
GRMN
53
3
ES
12
3
JCI
44
7
KMI
69
8
MDT
59
4
GT
43
2
FOX
71
3
FCX
44
4
CMA
42
3
APA
30
5
PM
49
8
CVS
27
2
MAR
57
3
EMC
30
-26
DIS
70
2
CAH
44
7
GOOGL
62
6
AZO
46
3
MMC
46
5
PCG
59
9
GRMN
53
3
ES
12
3
JCI
44
7
KMI
69
8
MDT
59
4
GT
43
2
FOX
71
3
FCX
44
4
CMA
42
3
APA
30
5
PM
49
8
CVS
27
2
MAR
57
3
EMC
30
-26
DIS
70
2
CAH
44
7
GOOGL
62
6
AZO
46
3
MMC
46
5
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
$51.50
Seasonality Move:
5.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's Legacy-Defining Momentor Strike

But the Surprising Way Trump Solves it Could Cement His Legacy.

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 23.4% based on the past 14 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 9 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.29%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $51.41. The Score for BIB is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 23.4% based on the past 14 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Sell
29
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 9 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.29%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
69.56
52-Week Low:
47.20

Prediction Charts

Market Cap:
0
Price in USD:
51.41
Volume:
7K
Beta:
1.82

Technical Analysis

SMA50:
59.76
SMA100:
61.99
SMA200:
59.78
52-Wk Change:
0.71%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 51.41 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 59.50 58.05 59.50 57.91
Dec-4 57.81 58.44 58.85 57.81
Dec-5 58.15 58.04 58.61 57.58
Dec-6 59.10 59.22 59.58 58.91
Dec-9 59.23 59.03 60.10 58.81
Dec-10 59.02 58.17 59.03 58.02
Dec-11 57.61 57.74 58.07 57.61
Dec-12 56.96 55.39 57.14 55.40
Dec-13 54.93 54.54 54.93 54.00
Dec-16 54.14 55.40 56.19 54.14
Dec-17 55.60 55.78 56.15 55.43
Dec-18 55.52 51.28 55.67 50.96
Dec-19 50.38 50.50 51.05 49.50
Dec-20 49.49 51.41 52.41 49.49

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.